The mean postoperative hip score for hip resurfacing is reported to be in the ‘excellent’ category in numerous published studies4,6,33,34,35.
Based on up-to-date systematic review of peer-reviewed literature published in 2019, MoM hip resurfacing is associated with superior outcomes when compared to THR4. The review includes findings such as decreased thigh pain6, less limp with walking6, improved function14, superior UCLA activity scores36, 37, quality of life36,37 and return to manual labour work36, moderate/heavy activity37, sport36 and long distance walking and running6.
Excellent results in well-selected patients
- Oxford scores for hip resurfacing patients were high compared to total hip replacement patients
- WOMAC scores indicated excellent function
- The UCLA Activity Scale showed that patients were regularly participating in moderate activity, with 10%
regularly participating in high impact sports
- Metal ion levels just 14% (cobalt) and 19% (chromium) of the limit used for the ASR recall and published
guidelines by the MHRA (cobalt 119 nmol/L, chromium 135 nmol/L)
- No failures associated with wear or increased metal ions in the resurfacing group
Patient reported outcomes recorded by the NJR, including the Oxford Hip Score and EQ-5D are higher for ADEPT® Hip Resurfacing than THR, however not statistically different when the NJR case-mix adjustment is applied31.
In other words, in terms of health gain and patient satisfaction following a hip operation, hip resurfacing is as equally valuable an operation as total hip replacement, which is considered to be one of the most successful and cost-effective interventions in medicine.
Patient satisfaction for the ADEPT® Hip Resurfacing is over 95%
ADEPT® Clinical Rationale
ADEPT® Operative Technique
Fill in your details below to download the ADEPT® Clinical Rationale
Fill in your details below to download the ADEPT® Flyer.
Fill in your details below to download the ADEPT® Operative Technique
Orthopaedic Data Evaluation Panel (ODEP)
The Orthopaedic Data Evaluation Panel (ODEP) was set up to monitor the NICE guidance on primary hip implants in 2002 and hip resurfacing in 2004. The Panel provides on-going assessment of hip implants to benchmark both hip femoral stems and hip acetabular cups against the NICE guidance, providing a benchmark rating for implant survivorship and data submission quality.